Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-24T12:32:59.306Z Has data issue: false hasContentIssue false

73 - West Nile Encephalitis Virus

from Part IV - Current Topics

Published online by Cambridge University Press:  15 December 2009

Michael S. Diamond
Affiliation:
Associate Editor, Associate Professor of Medicine, Molecular Microbiology, Pathology, and Immunology Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO
Rachel L. Chin
Affiliation:
University of California, San Francisco
Get access

Summary

INTRODUCTION

West Nile encephalitis virus (WNV) is a small, enveloped, mosquito-transmitted, positive-polarity RNA virus of the Flaviviridae family. This virus is closely related to other arthropod-borne viruses that cause human disease including dengue, yellow fever, and Japanese encephalitis viruses. WNV normally cycles in nature between mosquitoes and birds, but during epidemics will infect and cause disease in human, horses, and other vertebrate animals. Severe neurological disease in humans usually occurs within 1 to 2 weeks after mosquito inoculation and is more frequent in elderly and immunocompromised individuals.

EPIDEMIOLOGY

West Nile virus historically caused sporadic outbreaks of a mild febrile illness in regions of Africa, the Middle East, Asia, and Australia. However, in the 1990s, the epidemiology of infection appeared to change, with new outbreaks in parts of eastern Europe associated with higher rates of severe neurological disease. In 1999, WNV entered North America and caused seven human fatalities in the New York area, as well the deaths of a large number of birds and horses. Since then, WNV has spread to all 48 of the lower United States as well as to parts of Canada, Mexico, and the Caribbean. Because of the increased range, the number of human cases has continued to rise: In the United States between 1999 and 2007, there were more than 26,000 clinical cases of WNV, including nearly 1,000 deaths.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bakri, S J, Kaiser, P K. 2004. Ocular manifestations of West Nile virus. Curr Opin Ophthalmol 15: 537–40.CrossRefGoogle ScholarPubMed
Bode, A V, Sejvar, J J, Pape, W J, et al. West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis 2006; 42: 1234–40.CrossRefGoogle Scholar
Cunha, B A. Differential diagnosis of West Nile encephalitis. Curr Opin Infect Dis 2004; 17: 413–20.CrossRefGoogle ScholarPubMed
DeSalvo, D, Roy-Chaudhury, P, Peddi, R, et al. West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death. Transplantation 2004; 77: 466–9.CrossRefGoogle Scholar
Granwehr, B P, Lillibridge, K M, Higgs, S, et al. West Nile virus: where are we now?Lancet Infect Dis 2004; 4: 547–56.CrossRefGoogle ScholarPubMed
Hall, R A, Khromykh, A A. West Nile virus vaccines. Expert Opin Biol Ther 2004; 4: 1295–305.CrossRefGoogle ScholarPubMed
Hayes, E B, Sejvar, J J, Zaki, S R, et al. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 2005; 11: 1174–9.CrossRefGoogle ScholarPubMed
Kleinschmidt-DeMasters, B K, Marder, B D, Levi, M E, et al. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol 2004; 61: 1210–20.CrossRefGoogle ScholarPubMed
Leis, A A, Stokic, D S. Neuromuscular manifestations of Human West Nile Virus infection. Curr Treat Options Neurol 2005; 7: 15–22.CrossRefGoogle ScholarPubMed
Monath, T P, Liu, J, Kanesa-Thasan, N, et al. A live, attenuated recombinant West Nile virus vaccine. Proc Natl Acad Sci U S A 2006; 103: 6694–9.CrossRefGoogle ScholarPubMed
Mostashari, F, Bunning, M L, Kitsutani, P T, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358: 261–4.CrossRefGoogle ScholarPubMed
Nash, D, Mostashari, F, Fine, A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001; 344: 1807–14.CrossRefGoogle ScholarPubMed
Pealer, L N, Marfin, A A, Petersen, L R, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349: 1236–45.CrossRefGoogle ScholarPubMed
Sejvar, J J, Haddad, M B, Tierney, B C, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003; 290: 511–5.CrossRefGoogle ScholarPubMed
Watson, J T, Pertel, P E, Jones, R C, et al. Clinical characteristics and functional outcomes of West Nile fever. Ann Intern Med 2004; 141: 360–5.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • West Nile Encephalitis Virus
    • By Michael S. Diamond, Associate Editor, Associate Professor of Medicine, Molecular Microbiology, Pathology, and Immunology Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.074
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • West Nile Encephalitis Virus
    • By Michael S. Diamond, Associate Editor, Associate Professor of Medicine, Molecular Microbiology, Pathology, and Immunology Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.074
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • West Nile Encephalitis Virus
    • By Michael S. Diamond, Associate Editor, Associate Professor of Medicine, Molecular Microbiology, Pathology, and Immunology Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.074
Available formats
×